We will become the world’s most valued company to patients, customers, colleagues, investors, business partners and the communities where we work and live.
Our expertise and our products are helping to diagnose, alleviate or cure diseases, improving the quality and adequacy of the global food supply, and contributing significantly to an active, modern lifestyle. Our expertise and innovative capability also enable us to offer solutions for protecting the climate and addressing the consequences of climate change.
We are committed to the principles of sustainable development and to our role as a socially and ethically responsible corporate citizen. For us, there is a clear link between technical and economic expertise and our responsibility to work for the benefit of humankind, become socially involved and make a lasting contribution to sustainable development. At Bayer, we regard economy, ecology and social commitment as objectives of equal rank.
We seek to retain society’s confidence through performance, flexibility and open communication as we work in pursuit of our overriding goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.
The pharmaceutical industry is experiencing a time of unprecedented challenge. Patent expiries, regulatory issues and increased pressures from healthcare providers have combined to create an environment where our sector is associated with lower growth and higher risk.
We are addressing these challenges through three key strategic priorities that we believe will transform GSK into a company that delivers more growth, less risk and an improved financial performance.[sky]
Three strategic priorities
In 2008, we established the following three strategic priorities:
• Grow a diversified global business
• Deliver more products of value
• Simplify the operating model
Announcing GSK’s 2009 Annual Results, CEO Andrew Witty said, "Our strategy is delivering and I believe that GSK is now moving to a position where we can deliver our goal of long-term sustainable financial performance. 2009 saw GSK return to sales growth and I am confident of our prospects on 2010".
The values that guide our decision making are spelled out in Our Credo. Put simply, Our Credo challenges us to put the needs and well-being of the people we serve first.
Roche maintains open and honest relationships with our shareholders, prospective investors and the wider investment community. The role of Investor Relations is to manage these relationships efficiently, transparently and consistently in accordance with company polices and relevant securities rules and laws.
Our goals are to:
• Provide timely, relevant, consistent and accurate information to all shareholders and prospective investors to aid them in assessing the value of Roche and to make informed investment decisions
• Facilitate dialogue between Roche management and the investment community
• Achieve a fair valuation of Roche by the financial markets
As a company, AstraZeneca US is committed to a mission of improving human health.
The people of AstraZeneca are dedicated to:
• Discovering, developing, and delivering innovative, meaningful medicines and other healthcare solutions that help enrich the lives of patients, as well as their families and communities
• Putting the health of patients first by providing educational programs, resources, and tools designed to help empower and inform
• Creating a challenging and rewarding work environment that inspires our employees
[adsense1]From developing new therapies that treat and prevent disease to helping people in need, we’re committed to improving health and well-being around the world.
We are inspired by the difference we can make in the lives of people around the world through the innovative medicines, vaccines, and consumer health and animal products we discover and produce.
Our products cover a broad range of areas, including heart and respiratory health, infectious diseases, sun care and women’s health. And we focus our research on conditions that affect millions of people around the world – diseases like Alzheimer’s, diabetes and cancer – while building strengths in new areas like biologics.
While we work to develop innovative therapies, we also work hard to make sure they’re affordable. That’s why we offer assistance and discount programs to help make our medicines accessible to those who need them.
At today’s Merck, we’re applying our global reach and strength in scientific research to do more of what we’re passionate about: working to ensure a healthier future for all – one person at a time.
We bring to the world pharmaceutical and health care products that improve lives and deliver outstanding value to our customers and shareholders.
Our company’s mission is to extend and enhance human life by providing the highest-quality biopharmaceutical products.
[linkunit]When you or a family member or friend is diagnosed with an illness finding unbalanced and factual information you can trust is always a key priority. In this section is information about all the conditions our medicines are used to treat and links to organizations that can provide you with such information.
Our mission includes finding answers for some of the world´s unmet medical needs. We focus our internal research efforts primarily on four core therapeutic areas: neuroscience; endocrine disorders; cancer; and cardiovascular diseases.
We also continue to pursue innovative science and new opportunities beyond our targeted disease categories. We embrace a philosophy of "research innovation without walls," meaning that we pursue cutting-edge science and technology from external, as well as internal, sources.
In the last decade, we have introduced important new drugs for the treatment of cancer, schizophrenia, osteoporosis, diabetes, cardiovascular complications and severe sepsis. Our pipeline, one of the strongest in the industry, has the potential to address many serious unmet medical needs of people around the world.
Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives. In everything we do, we aim to fulfill our mission to serve patients. And every step of the way, we are guided by the values that define us.
Our Mission: To Serve Patients
Our Values
• Be Science-Based
• Compete Intensely and Win
• Create Value for Patients, Staff and Stockholders
• Be Ethical
Page: 1 2
Microsoft Corporation also known as MS is one of the biggest multinational technology-based company in…
The article is based upon in-depth analysis of Fast Food Industry of Australian Region with…
The paper presents detailed overview about the Apple Inc. analysis on the parameters set by…
The purpose of this research paper is to develop a marketing plan for the Thomson…
1. As applicable to other department managers, a human resources manager invigilates the departments and…
The purpose of the present article is to formulate a work allocation flow chart of…
View Comments
write mission statments of gsk briefly, for a customer to know them easily